ESS vs FOLD · P/E 31, rev $1.89B vs rev $528.3M
Essex Property Trust Inc (ESS) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the ESS and FOLD stock pages for the full models.
Not investment advice.